Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Clin J Pain. 2023 Feb 1;39(2):76–84. doi: 10.1097/AJP.0000000000001090

Table 1.

Demographics of patients undergoing breast surgery

Variable N (%), mean ± SD
Demographics
Age 55.5±12.4
Body Mass Index (BMI) 27.4±6.2
Education
 Some HS 4 (1.5%)
 HS grad/GED 20 (7.7%)
 Tech School 2 (0.8%)
 Some College 35 (13.5%)
 College Graduate 104 (40.2%)
 Master’s Degree 68 (26.3%)
 Doctoral Degree 24 (9.3%)
Race/ethnicity*
 Caucasian 223 (86.4%)
 African American 7 (2.7%)
 Hispanic/Latina 5 (1.9)
 Asian 11 (4.3%)
 Mixed race 8 (3.1%)
 Other 4 (1.6%)
Surgical Variables
Surgery/reconstruction type, n (%)
 Breast conserving surgery (Lumpectomy) 136 (52.5%)
 Mastectomy 34 (13.1%)
 Mastectomy with reconstruction - tissue expander 68 (26.3%)
 Mastectomy with reconstruction - autologous 21 (8.1%)
Node surgery type, n (%)
 No axillary surgery 52 (20.1%)
 Sentinel lymph node procedure 165 (63.7%)
 Axillary lymph node dissection 42 (16.2%)
Medical Treatment within first year after surgery
 Radiation therapy, n(%) 146 (57.3%)
 Chemotherapy, n (%) 92 (35.9%)
 Hormone therapy, n (%) 126 (49.6%)
Baseline pain (Breast Cancer Pain questionnaire, BCPQ)
 Pain Severity Index (PSI) (severity x frequency in 4 surgical areas), mean±SD 4.1±9.3
 Surgical Area Pain Severity, mean±SD 1.2±1.8
 Physical Impact, mean±SD 1.0±2.6
 BPI Average Pain, mean±SD 1.1±1.6
 BPI Impairment mean±SD 9.3±17.5
 Severity of chronic pain in other area(s), mean±SD 1.7±2.5
Opioid use at baseline, n (%) 13 (5.1%)
Psychosocial Variables at baseline
 Pain Catastrophizing Scale (PCS total), mean±SD 6.4±6.9
 Anxiety (PROMIS SF), mean t score ±SD 46.2±6.5
 Depression (PROMIS SF), mean t score±SD 38.9±7.4
 Sleep Disturbance (PROMIS SF), mean t score ±SD 50.62±8.9
 Negative Affect (PANAS; range: 10–50), mean±SD 17.5±5.9
 Positive Affect (PANAS; range: 10–50), mean±SD 34.1±7.4
 Somatization (BSI; range: 6–30), mean±SD 7.0±2.2